# Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-iii-keynote-789-study-of-pemetrexed-and-platinum-with-or-without/

## Facts

| Field | Value |
| --- | --- |
| Author Names | James Chih‐Hsin Yang,Dae Ho Lee,Jong‐Seok Lee,Yun Fan,Filippo de Marinis,Eiji Iwama,Takako Inoue,Jerónimo Rafael Rodríguez‐Cid,Li Zhang,Cheng‐Ta Yang,Emmanuel de la Mora Jimenez,Jianying Zhou,M. Pérol,Ki Hyeong Lee,David Vicente,Eiki Ichihara,Gregory J. Riely,Yiwen Luo,Diana Chirovsky,M. Catherine Pietanza,Niyati Bhagwati,Shun Lü,Michael Boyer,Rina Hui,Mark E. Wong,Andrew Mant,Phillip Parente,Thomas John,Sagun Parakh,Gilberto de Castro,Gustavo Werutsky,Sérgio Jobim Azevedo,Fábio Franke,Joilda Batista De Almeida Rego,Pedro Rafael Martins De Marchi,Gustavo Dix Junqueira,Fernanda Maris Peria,Leandro Brust,Parneet Cheema,Mark Doherty,Ambika Parmar,Ines B. Menjak,Natasha B. Leighl,Jason Agulnik,Shun Lü,Zhigang Han,Jiuwei Cui,Li Zhang,Ying Cheng,Gongyan Chen,Helong Zhang,Yu Yao,Chengping Hu,Qiming Wang,Xin Zhang,Yong Zhang,Jianying Zhou,Kejing Ying,Yun Fan,Yan Wang,Ziping Wang,Ji‐Feng Feng,Yingying Du,Lin Wu,Cheng Zhi Huang,Xiangdong Zhou,M. Pérol,Julien Dômont,Corinne Lamour,Julien Dutilh,Youssef Oulkhouir,Virginie Westeel,D. Carmier,Bruno Coudert,Aurélie Lagrange,Dominique Spaëth,Stanislas Ropert,Daniel C. Christoph,Jens Kern,Hans‐Georg Kopp,Frank Griesinger,Rainer Wiewrodt,Martin Wermke,Claas Wesseler,Annette Mueller,G Vogel,Victor Lee,Chung Man James Ho,Siu Hong Oscar Chan,Sing Hung Lo,Shi Feng Jonathan Nyaw,Yu Chung Jacky Li,Jair Bar,Maya Gottfried,Julia Dudnik,Alona Zer,Mor Moskovitz,Mirjana Wollner,Ofer Rotem,Sivan Shamai |
| Citations | 153 |
| DOI | 10.1200/jco.23.02747 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1200/jco.23.02747 |
| OpenAlex ID | https://openalex.org/W4401742667 |
| PMID | 39173098 |
| Type | article |
| Year | 2024 |

## Paper authors

- [James Chih‐Hsin Yang](https://scholariq.org/researchers/james-chih-hsin-yang/)
- [Jair Bar](https://scholariq.org/researchers/jair-bar/)
- [Lin Wu](https://scholariq.org/researchers/lin-wu/)
- [Gregory J. Riely](https://scholariq.org/researchers/gregory-j-riely/)
- [Keisuke Kirita](https://scholariq.org/researchers/keisuke-kirita/)
- [Te‐Chun Hsia](https://scholariq.org/researchers/te-chun-hsia/)
- [Gee‐Chen Chang](https://scholariq.org/researchers/gee-chen-chang/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.